Wouter T. R. Hooghiemstra

HDAC 3-selective inhibitor RGFP966 demonstrates anti-inflammatory properties in RAW 264.7 macrophages and mouse precision-cut lung slices by attenuating NF-κB p65 transcriptional activity

Niek G.J. Leus, Petra E. van der Wouden, Thea van den Bosch et al. · Biochemical Pharmacology · 2016 · 137 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +17

Fluorescence-guided imaging for resection margin evaluation in head and neck cancer patients using cetuximab-800CW: A quantitative dose-escalation study

Floris J. Voskuil, Steven J. de Jongh, Wouter T. R. Hooghiemstra et al. · Theranostics · 2020 · 117 citations · Full text

Medicine, Oncology, Biomedical Imaging +15

EGFR-targeted fluorescence molecular imaging for intraoperative margin assessment in oral cancer patients: a phase II trial

Jaron G. de Wit, Jasper Vonk, Floris J. Voskuil et al. · Nature Communications · 2023 · 90 citations · Full text

Medicine, Oncology, Molecular Imaging +16

Multispectral optoacoustic tomography for in vivo detection of lymph node metastases in oral cancer patients using an EGFR-targeted contrast agent and intrinsic tissue contrast: A proof-of-concept study

Jasper Vonk, Jan Kukačka, Pieter J. Steinkamp et al. · Photoacoustics · 2022 · 30 citations · Full text

Medicine, Cancer Biology, Oncology +16

Detection of Early Esophageal Neoplastic Barrett Lesions with Quantified Fluorescence Molecular Endoscopy Using Cetuximab-800CW

Ruben Y. Gabriëls, Lisanne E. van Heijst, Wouter T. R. Hooghiemstra et al. · Journal of Nuclear Medicine · 2023 · 26 citations · Full text

Medicine, Molecular Medicine, Oncology +17